Inclacumab Biosimilar - Research Grade

Human

SELPï؟½

5mg/ml

IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P16109

Blue ice

P-selectin (SELP) mediates leukocyte rolling and platelet adhesion at sites of vascular inflammation and thrombosis. Recognizing the human protein, this unconjugated, non-therapeutic analog of inclacumab is a recombinant human IgG4, kappa monoclonal intended for research use only (RUO). The material ships in a low-endotoxin format engineered for in vivo applications and is prepared in scalable milligram to gram quantities to keep heavy-usage and bulk laboratories well supplied. Researchers apply it to adhesion and cell-binding assays, neutralization studies, in vitro screening, and preclinical models of inflammatory and cardiovascular disease, where it serves as a steady control during functional and biologics-focused investigations.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks